← Browse by Condition
Medical Condition
primary immune deficiency disorder
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT03266627 Phase 2
Recruiting
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
Enrollment
20 pts
Location
United States
Sponsor
New York Medical College
NCT03266653 Phase 2
Recruiting
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Enrollment
20 pts
Location
United States
Sponsor
New York Medical College
NCT03266640 Phase 2
Recruiting
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Enrollment
20 pts
Location
United States
Sponsor
New York Medical College